Evangelos Koustas

4.7k total citations · 1 hit paper
53 papers, 1.4k citations indexed

About

Evangelos Koustas is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Evangelos Koustas has authored 53 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 22 papers in Oncology and 18 papers in Epidemiology. Recurrent topics in Evangelos Koustas's work include Autophagy in Disease and Therapy (11 papers), MicroRNA in disease regulation (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Evangelos Koustas is often cited by papers focused on Autophagy in Disease and Therapy (11 papers), MicroRNA in disease regulation (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Evangelos Koustas collaborates with scholars based in Greece, Germany and United States. Evangelos Koustas's co-authors include Michalis V. Karamouzis, Panagiotis Sarantis, Athanasios G. Papavassiliou, Adriana Papadimitropoulou, Dimitriοs Schizas, Amanda Psyrri, Dimitrios C. Ziogas, Nikolaos Charalampakis, Panagiota Economopoulou and Christo Kole and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Evangelos Koustas

48 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunotherapy for pancreatic cancer: A 2020 update

2020 308 citations Dimitriοs Schizas, Nikolaos Charalampakis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Evangelos Koustas Greece	19	702	642	348	234	223	53	1.4k
Yitian Chen China	18	466 0.7×	583 0.9×	424 1.2×	156 0.7×	183 0.8×	45	1.3k
Hao‐Xiang Wu China	22	596 0.8×	520 0.8×	393 1.1×	127 0.5×	251 1.1×	38	1.3k
Sunbin Ling China	19	533 0.8×	790 1.2×	402 1.2×	265 1.1×	108 0.5×	50	1.4k
Juanjuan Shi China	22	403 0.6×	838 1.3×	374 1.1×	130 0.6×	316 1.4×	39	1.4k
Xiaoying Wang China	13	460 0.7×	489 0.8×	276 0.8×	267 1.1×	226 1.0×	52	1.3k
Panagiotis Sarantis Greece	19	476 0.7×	503 0.8×	247 0.7×	156 0.7×	130 0.6×	75	1.1k
Si‐Rui Ma China	23	719 1.0×	814 1.3×	405 1.2×	284 1.2×	598 2.7×	53	1.8k
Le‐Qun Li China	20	542 0.8×	685 1.1×	598 1.7×	229 1.0×	246 1.1×	63	1.5k
Yitao Gong China	11	787 1.1×	859 1.3×	504 1.4×	237 1.0×	239 1.1×	27	1.6k

Countries citing papers authored by Evangelos Koustas

Since Specialization

Citations

This map shows the geographic impact of Evangelos Koustas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evangelos Koustas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evangelos Koustas more than expected).

Fields of papers citing papers by Evangelos Koustas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evangelos Koustas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evangelos Koustas. The network helps show where Evangelos Koustas may publish in the future.

Co-authorship network of co-authors of Evangelos Koustas

This figure shows the co-authorship network connecting the top 25 collaborators of Evangelos Koustas. A scholar is included among the top collaborators of Evangelos Koustas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evangelos Koustas. Evangelos Koustas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sarantis, Panagiotis, et al.. (2025). Biomarkers for the Evaluation of Immunotherapy in Patients with Cholangiocarcinoma. Cancers. 17(3). 555–555. 3 indexed citations

Koustas, Evangelos, et al.. (2025). Autophagy and PXR Crosstalk in the Regulation of Cancer Drug Metabolism and Resistance According to Gene Mutational Status in Colorectal Cancer. Genes. 16(8). 892–892.

Sarantis, Panagiotis, Nikolaos Charalampakis, Evangelos Koustas, et al.. (2024). Progastrin: An Overview of Its Crucial Role in the Tumorigenesis of Gastrointestinal Cancers. Biomedicines. 12(4). 885–885.

Anastasiou, Ioanna A., Panagiotis Sarantis, Eleni Rebelos, et al.. (2024). l‐Securinine Induces ROS‐Dependent Apoptosis on Pancreatic Cancer Cells via the PI3K/AKT/mTOR Signaling Pathway. Journal of Biochemical and Molecular Toxicology. 38(11). e70036–e70036.

Sarantis, Panagiotis, et al.. (2023). Predictive Biomarkers for Immune-Related Endocrinopathies following Immune Checkpoint Inhibitors Treatment. Cancers. 15(2). 375–375. 18 indexed citations

Psilopatis, Iason, Christos Damaskos, Nikolaos Garmpis, et al.. (2023). The Role of Hyperthermic Intraperitoneal Chemotherapy in Uterine Cancer Therapy. International Journal of Molecular Sciences. 24(15). 12353–12353. 7 indexed citations

Psilopatis, Iason, Christos Damaskos, Anna Garmpi, et al.. (2023). FDA-Approved Monoclonal Antibodies for Unresectable Hepatocellular Carcinoma: What Do We Know So Far?. International Journal of Molecular Sciences. 24(3). 2685–2685. 16 indexed citations

Psilopatis, Iason, Nikolaos Garmpis, Anna Garmpi, et al.. (2023). The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy. Cancers. 15(8). 2222–2222. 18 indexed citations

Koustas, Evangelos, Panagiotis Sarantis, Nikolaos Papadopoulos, et al.. (2023). Exploiting Autophagy-Dependent Neoantigen Presentation in Tumor Microenvironment. Genes. 14(2). 474–474. 12 indexed citations

10.

Messaritakis, Ippokratis, Maria Sfakianaki, Alexandra Voutsina, et al.. (2022). Prognostic Value of KRAS Mutations in Colorectal Cancer Patients. Cancers. 14(14). 3320–3320. 41 indexed citations

11.

Koustas, Evangelos, Panagiotis Sarantis, Nikolaos Papadopoulos, et al.. (2022). Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer—Current Treatment Options and Future Perspectives. International Journal of Molecular Sciences. 23(12). 6664–6664. 24 indexed citations

12.

Damaskos, Christos, Nikolaos Garmpis, Dimitrios Dimitroulis, et al.. (2022). The Role of SNHG15 in the Pathogenesis of Hepatocellular Carcinoma. Journal of Personalized Medicine. 12(5). 753–753. 4 indexed citations

13.

Sarantis, Panagiotis, et al.. (2022). Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors. International Journal of Molecular Sciences. 23(21). 13612–13612. 7 indexed citations

14.

Koustas, Evangelos, Panagiotis Sarantis, Nikolaos Papadopoulos, et al.. (2022). Implication of gut microbiome in immunotherapy for colorectal cancer. World Journal of Gastrointestinal Oncology. 14(9). 1665–1674. 7 indexed citations

15.

Papadopoulos, Nikolaos, et al.. (2022). Hepatitis C Virus Infections in Patients with Hemophilia: Links, Risks and Management. Journal of Multidisciplinary Healthcare. Volume 15. 2301–2309. 2 indexed citations

16.

Damaskos, Christos, Nikolaos Garmpis, Anna Garmpi, et al.. (2021). Investigational Drug Treatments for Triple-Negative Breast Cancer. Journal of Personalized Medicine. 11(7). 652–652. 14 indexed citations

17.

Garmpis, Nikolaos, Christos Damaskos, Anna Garmpi, et al.. (2021). Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities. Journal of Personalized Medicine. 11(3). 223–223. 26 indexed citations

18.

Levidou, Georgia, Panagiotis Sarantis, Evangelos Koustas, et al.. (2021). HuR Protein in Hepatocellular Carcinoma: Implications in Development, Prognosis and Treatment. Biomedicines. 9(2). 119–119. 21 indexed citations

19.

Sarantis, Panagiotis, et al.. (2020). The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpoint Inhibitors and Anti-RANKL. International Journal of Molecular Sciences. 21(20). 7570–7570. 16 indexed citations

20.

Karamouzis, Michalis V., Panagiotis Sarantis, Evangelos Koustas, et al.. (2020). 1550P Combination therapy of low molecular weight heparins, chemotherapy and immunotherapy induce antitumor activity in pancreatic cancer. Annals of Oncology. 31. S949–S949. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact